Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The global burden of HIV-1 drug resistance in the past 20 years

25 May 2018

Abstract excerpt

Genotypic drug resistance testing has been an integral part of the clinical management of HIV patients for almost 20 years, not only assisting treatment choices but also informing drug development. Accurate estimations on the worldwide circulation of drug resistance are difficult to obtain, particularly in low/middle-income countries. In this work, we queried two of the largest public HIV sequence repositories in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to HIV/AIDS drug development and treatment
Share to HIV/AIDS Research and Interventions
Share to HIV Research and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29844989
DOI: 10.7717/peerj.4848

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The global burden of HIV-1 drug resistance in the past 20 yearsPMID 29844989Read ↗

Prevalence of transmitted HIV-1 drug resistance among treatment-naive individuals in China, 2000-2016.Semantic proximity Read ↗

Prevalence of Transmitted HIV-1 Drug Resistance Among Treatment-naive Individuals in China, 2000-2016Semantic proximity Read ↗

Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis.Semantic proximity Read ↗

Changing Proportions of HIV-1 Subtypes and Transmitted Drug Resistance Among Newly Diagnosed HIV/AIDS Individuals — China, 2015 and 2018Semantic proximity Read ↗

HIV-1 drug resistance and resistance testing.Semantic proximity Read ↗

Transmitted drug resistance and subtype patterns of viruses from reported new HIV diagnoses in Germany, 2017-2020.Semantic proximity Read ↗

Patterns of Transmitted Drug Resistance Mutations and HIV-1 Subtype Dynamics in ART-Naïve Individuals in Veneto, Italy, from 2017 to 2024.Semantic proximity Read ↗

HIV-1 drug resistance and genetic transmission network among newly diagnosed people living with HIV/AIDS in Ningbo, China between 2018 and 2021.Semantic proximity Read ↗

Pretreatment HIV Drug Resistance and the Molecular Transmission Network Among HIV-Positive Individuals in China in 2022: Multicenter Observational StudySemantic proximity Read ↗

Prevalence and trends in human immunodeficiency virus-1 subtypes and drug resistance in South Korea: Analysis of 5 years’ data (2017‒2022)Semantic proximity Read ↗

Brazilian network for HIV Drug Resistance Surveillance (HIV-BresNet): a survey of treatment-naive individuals.Semantic proximity Read ↗

Human Immunodeficiency Virus Drug Resistance: 2018 Recommendations of the International Antiviral Society–USA PanelSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.